Helsinki University Central Hospital

At Helsinki University Central Hospital the Heart and Lung Center concentrates on coronary artery disease, seeking to advance interventional care for patients with elevated bleeding risk.

• Evaluation of drug‑coated balloon therapy
• Comparison with drug‑eluting stents
• Shortened dual‑antiplatelet therapy regimens
• Strategies for high bleeding risk populations

Ongoing studies aim to demonstrate that a drug‑coated balloon approach combined with reduced dual‑antiplatelet therapy can be as effective as traditional drug‑eluting stents, offering safer options for those prone to bleeding.